CDXS
Codexis Inc
1.30$
-3.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 66.7% | 68.4% | 72.2% | 69.2% | 76.2% | 66.3% | 60.4% | 64.2% | 61.5% | 65.5% | 61.6% | 59.9% | |
| 48.3% | 47.7% | 38.8% | 14.1% | 25.3% | 12.9% | 14.2% | 19.4% | 20.8% | 34.4% | 28.6% | 22.6% | |
| 48.3% | 47.7% | 57.2% | 55.5% | 60.9% | 49.3% | 46.4% | 48.0% | 47.7% | 52.9% | 50.7% | 45.7% | |
| 12.4% | 14.6% | 9.5% | 9.4% | 11.2% | 12.7% | 9.0% | 11.9% | 7.9% | 7.3% | 6.2% | 6.1% | |
| 1.5% | 2.0% | 1.6% | 1.7% | 1.4% | 1.2% | 1.4% | 1.4% | 1.6% | 1.2% | 1.5% | 1.3% | |
| 18.9% | – | – | – | – | – | – | – | – | – | – | – | |
| 1.6% | 1.8% | 1.6% | 1.9% | 1.7% | 1.7% | 1.9% | 1.8% | 2.0% | 1.7% | 1.9% | 2.1% | |
| 40.8% | 36.6% | 47.0% | 53.5% | 50.5% | 55.1% | 61.5% | 59.8% | 68.9% | 65.8% | 66.6% | 72.5% | |
| 24.9% | 26.2% | 19.4% | 23.1% | 23.7% | 15.9% | 16.2% | 11.0% | 14.9% | 17.1% | 11.5% | 19.6% | |
| 4.4% | 2.8% | 2.6% | 3.0% | 2.8% | 1.9% | 2.3% | 2.2% | 2.5% | 2.0% | 2.6% | 8.6% | |
| 2.0% | 4.4% | 2.3% | 2.8% | 2.8% | 1.9% | 4.7% | 1.1% | 2.0% | 1.1% | 1.6% | 2.2% | |
| – | – | 18.8% | 21.5% | 19.3% | 19.4% | 22.6% | 28.5% | 32.0% | 27.1% | 31.3% | 28.2% | |
| 59.2% | 63.4% | 53.0% | 46.5% | 49.5% | 44.9% | 38.5% | 40.2% | 31.1% | 34.2% | 33.4% | 27.5% | |
| -317.5% | -364.3% | -340.4% | -402.9% | -372.8% | -377.7% | -452.7% | -431.7% | -497.2% | -410.5% | -475.8% | -522.7% | |
| 45.0% | 50.9% | 46.7% | 53.3% | 48.6% | 54.6% | 63.9% | 61.8% | 72.8% | 61.5% | 70.2% | 75.8% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.